Moreover, the increased LCN2 mRNA levels detected in IPF patients suggest that LCN2 levels can be used as surrogate biomarkers of pulmonary inflammation and a possible indicator of compromised pulmonary functions, urging for larger studies. This evidence concerns the gene LCN2 and idiopathic pulmonary fibrosis.